204 related articles for article (PubMed ID: 10087067)
1. CNS wound healing is severely depressed in metallothionein I- and II-deficient mice.
Penkowa M; Carrasco J; Giralt M; Moos T; Hidalgo J
J Neurosci; 1999 Apr; 19(7):2535-45. PubMed ID: 10087067
[TBL] [Abstract][Full Text] [Related]
2. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice.
Penkowa M; Giralt M; Carrasco J; Hadberg H; Hidalgo J
Glia; 2000 Dec; 32(3):271-85. PubMed ID: 11102968
[TBL] [Abstract][Full Text] [Related]
3. Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice.
Penkowa M; Giralt M; Moos T; Thomsen PS; Hernández J; Hidalgo J
Exp Neurol; 1999 Mar; 156(1):149-64. PubMed ID: 10192786
[TBL] [Abstract][Full Text] [Related]
4. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice.
Penkowa M; Moos T; Carrasco J; Hadberg H; Molinero A; Bluethmann H; Hidalgo J
Glia; 1999 Feb; 25(4):343-57. PubMed ID: 10028917
[TBL] [Abstract][Full Text] [Related]
5. Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice.
Carrasco J; Penkowa M; Hadberg H; Molinero A; Hidalgo J
Eur J Neurosci; 2000 Jul; 12(7):2311-22. PubMed ID: 10947810
[TBL] [Abstract][Full Text] [Related]
6. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice.
Penkowa M; Carrasco J; Giralt M; Molinero A; Hernández J; Campbell IL; Hidalgo J
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1174-89. PubMed ID: 10950378
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein-1+2 protect the CNS after a focal brain injury.
Giralt M; Penkowa M; Lago N; Molinero A; Hidalgo J
Exp Neurol; 2002 Jan; 173(1):114-28. PubMed ID: 11771944
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures.
Penkowa M; Molinero A; Carrasco J; Hidalgo J
Neuroscience; 2001; 102(4):805-18. PubMed ID: 11182244
[TBL] [Abstract][Full Text] [Related]
9. IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment.
Penkowa M; Hidalgo J
Exp Neurol; 2000 May; 163(1):72-84. PubMed ID: 10785446
[TBL] [Abstract][Full Text] [Related]
10. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury.
Penkowa M; Giralt M; Lago N; Camats J; Carrasco J; Hernández J; Molinero A; Campbell IL; Hidalgo J
Exp Neurol; 2003 Jun; 181(2):130-48. PubMed ID: 12781987
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M; Giralt M; Camats J; Hidalgo J
J Comp Neurol; 2002 Mar; 444(2):174-89. PubMed ID: 11835189
[TBL] [Abstract][Full Text] [Related]
12. Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice.
Wiese L; Kurtzhals JA; Penkowa M
Exp Neurol; 2006 Jul; 200(1):216-26. PubMed ID: 16624296
[TBL] [Abstract][Full Text] [Related]
13. M-CSF deficiency leads to reduced metallothioneins I and II expression and increased tissue damage in the brain stem after 6-aminonicotinamide treatment.
Penkowa M; Poulsen C; Carrasco J; Hidalgo J
Exp Neurol; 2002 Aug; 176(2):308-21. PubMed ID: 12359172
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein-null mice are more sensitive than wild-type mice to liver injury induced by repeated exposure to cadmium.
Habeebu SS; Liu J; Liu Y; Klaassen CD
Toxicol Sci; 2000 May; 55(1):223-32. PubMed ID: 10788577
[TBL] [Abstract][Full Text] [Related]
15. Basic science; metallothionein I and II attenuate the thalamic microglial response following traumatic axotomy in the immature brain.
Potter EG; Cheng Y; Knight JB; Gordish-Dressman H; Natale JE
J Neurotrauma; 2007 Jan; 24(1):28-42. PubMed ID: 17263668
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte-targeted expression of interleukin-3 and interferon-alpha causes region-specific changes in metallothionein expression in the brain.
Giralt M; Carrasco J; Penkowa M; Morcillo MA; Santamaría J; Campbell IL; Hidalgo J
Exp Neurol; 2001 Apr; 168(2):334-46. PubMed ID: 11259121
[TBL] [Abstract][Full Text] [Related]
17. Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury.
Penkowa M; Tio L; Giralt M; Quintana A; Molinero A; Atrian S; Vasák M; Hidalgo J
J Neurosci Res; 2006 May; 83(6):974-84. PubMed ID: 16493670
[TBL] [Abstract][Full Text] [Related]
18. Novel roles for metallothionein-I + II (MT-I + II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I + II knockout mice.
Penkowa M; Cáceres M; Borup R; Nielsen FC; Poulsen CB; Quintana A; Molinero A; Carrasco J; Florit S; Giralt M; Hidalgo J
J Neurosci Res; 2006 Nov; 84(7):1452-74. PubMed ID: 16941634
[TBL] [Abstract][Full Text] [Related]
19. Metallothionein-IIA promotes initial neurite elongation and postinjury reactive neurite growth and facilitates healing after focal cortical brain injury.
Chung RS; Vickers JC; Chuah MI; West AK
J Neurosci; 2003 Apr; 23(8):3336-42. PubMed ID: 12716941
[TBL] [Abstract][Full Text] [Related]
20. Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains.
Carrasco J; Giralt M; Molinero A; Penkowa M; Moos T; Hidalgo J
J Neurotrauma; 1999 Nov; 16(11):1115-29. PubMed ID: 10595827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
